UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

 

Transact Technologies Incorporated

(Name of Issuer)

 

Common Stock, $0.01 par value

Common Stock, Par Value $0.001 per share
(Title of Class of Securities)

 

892918103
(CUSIP Number)

 

Michael Braner

325 Capital LLC

200 Park Avenue 17th Floor

New York, NY 10016

646-774-2904

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 
July 8, 2021

(Date of Event which Requires

Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

   
 

 

SCHEDULE 13D

               
CUSIP No. 892918103   Page 2 of 9

 

1

 

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 32-0588582

 

 

325 Capital LLC

 

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

 

(a)

 

o

 
 

 

 

 

(b)

 

 

o

 

 

3

 

SEC USE ONLY

 

 

4

 

SOURCE OF FUNDS (SEE INSTRUCTIONS)

  OO

 

5

 

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

o

 

 

 

6

 

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

7

 

SOLE VOTING POWER

  0

 

8

 

SHARED VOTING POWER

  573,889

 

9

 

SOLE DISPOSITIVE POWER

  0

 

10

 

SHARED DISPOSITIVE POWER

  573,889

 

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see(see INSTRUCTIONS)

 

o

 

 

  (SEE INSTRUCTIONS)

 

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

  6.4%

 

14

 

TYPE OF REPORTING PERSON

  IA

 

   
 

               
CUSIP No. 892918103   Page 3 of 9

 

1

 

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

 

Michael Braner

 

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

 

(a)

 

o

 
 

 

 

 

(b)

 

 

o

 

 

3

 

SEC USE ONLY

 

 

4

 

SOURCE OF FUNDS (SEE INSTRUCTIONS)

  OO

 

5

 

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

o

 

 

 

6

 

CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

7

 

SOLE VOTING POWER

  0

 

8

 

SHARED VOTING POWER

  573,889

 

9

 

SOLE DISPOSITIVE POWER

  0

 

10

 

SHARED DISPOSITIVE POWER

  573,889

 

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see(see INSTRUCTIONS)

 

o

 

 

  (SEE INSTRUCTIONS)

 

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

  6.4%

 

14

 

TYPE OF REPORTING PERSON

  IN

 

   
 

               
CUSIP No. 892918103   Page 4 of 9

 

1

 

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

 

Daniel Friedberg

 

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

 

(a)

 

o

 
 

 

 

 

(b)

 

 

o

 

 

3

 

SEC USE ONLY

 

 

4

 

SOURCE OF FUNDS (SEE INSTRUCTIONS)

  OO

 

5

 

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

o

 

 

 

6

 

CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

7

 

SOLE VOTING POWER

  0

 

8

 

SHARED VOTING POWER

  573,889

 

9

 

SOLE DISPOSITIVE POWER

  0

 

10

 

SHARED DISPOSITIVE POWER

  573,889

 

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see(see INSTRUCTIONS)

 

o

 

 

  (SEE INSTRUCTIONS)

 

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

  6.4%

 

14

 

TYPE OF REPORTING PERSON

  IN

 

   
 

               
CUSIP No. 892918103   Page 5 of 9

 

1

 

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

 

Anil Shrivastava

 

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

 

(a)

 

o

 
 

 

 

 

(b)

 

 

o

 

 

3

 

SEC USE ONLY

 

 

4

 

SOURCE OF FUNDS (SEE INSTRUCTIONS)

  OO

 

5

 

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

o

 

 

 

6

 

CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

7

 

SOLE VOTING POWER

  0

 

8

 

SHARED VOTING POWER

  573,889

 

9

 

SOLE DISPOSITIVE POWER

  0

 

10

 

SHARED DISPOSITIVE POWER

  573,889

 

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see(see INSTRUCTIONS)

 

o

 

 

  (SEE INSTRUCTIONS)

 

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

  6.4%

 

14

 

TYPE OF REPORTING PERSON

  IN

 

   
 

 

Page 6 of 9

 

Item 1. Security and Issuer.

 

This Schedule 13D (this “Statement”) relates to the Common Stock, $0.01 par value per share (the “Shares”) of Transact Technologies Incorporated, a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 1 Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, Connecticut 06518.

 

Item 2. Identity and Background.

 

(a) - (c) and (f).

 

The persons filing this Schedule 13D are 325 Capital LLC, a Delaware limited liability company (“325”), Michael Braner, a United States citizen, Daniel Friedberg, a United States citizen, and Anil Shrivastava, a United States citizen (collectively, the “Reporting Persons”).

 

325’s principal business is to serve as an investment adviser to certain affiliated investment funds and to separately managed accounts (collectively, “Clients”). Messrs. Braner, Friedberg, and Shrivastava are Managing Partners of 325.

 

For each of the Reporting Persons, the principal business address, which also serves as the principal office, is 200 Park Avenue, 17th Floor, New York, NY 10016.

 

(d) – (e).

 

During the last five years, none of the Reporting Persons, nor any of their respective directors or executive officers have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding was, or is, subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, United States federal or state securities laws or finding any violation with respect to such laws.

 

 

Item 3. Source and Amount of Funds or Other Consideration.

 

As of the date hereof, the Reporting Persons are deemed to beneficially own the Shares as detailed in Item 1 and 5. The aggregate purchase price for the Shares is $7,414,708 (exclusive of brokerage commissions and other costs of execution).

 

The source of funding for the transactions pursuant to which the Reporting Persons obtained beneficial ownership of the Shares was derived from the respective capital of the Clients.

 

Item 4. Purpose of Transaction.

 

The Reporting Persons acquired the Shares beneficially owned by them for the purpose of acquiring a significant equity position in the Issuer.

 

The Reporting Persons may acquire additional Shares or other securities of the Issuer or may dispose of any or all of their Shares or other securities of the Issuer from time to time depending upon an ongoing evaluation of the Shares, the Issuer, prevailing market conditions, other investment opportunities, liquidity requirements of the Reporting Persons, the Issuer’s reactions to the discussions below and/or other considerations.

 

Also, the Reporting Persons may engage in communications with one or more shareholders of the Issuer, one or more officers or employees of the Issuer, one or more members of the board of directors of the Issuer (and/or committees thereof) and/or one or more representatives of the Issuer regarding the Issuer, including but not limited to its operations, business, results, plans, strategy, existing and new markets and customers, budgets, prospects, ownership structure, management team composition, board composition (which could include the idea that a representative(s) of the Reporting Persons be nominated or elected to the board of directors of the Issuer) and management.  The Reporting Persons may discuss ideas that are consistent with, that complement, or that diverge from, the Issuer’s current and future strategy and initiatives.  The Reporting Persons may discuss ideas that, if effected, may result in acquisitions by persons of additional securities of the Issuer, an extraordinary corporate transaction involving the Issuer, changes in the Issuer’s capitalization and/or changes in the board of directors or management of the Issuer.

 

Except to the extent the foregoing may be deemed a plan or proposal, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D.  The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.

 

   
 

 

Page 7 of 9

 

Item 5. Interest in Securities of the Issuer.

 

(a) As of July 20, 2021, each Reporting Person beneficially owned 573,889 Shares, which represented 6.4% of the outstanding Shares, based upon 8,965,541 Shares outstanding on the Issuer’s Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2021.

 

The beneficial ownership reflected in the remainder of this Item 5, and in the cover pages, reflect beneficial ownership as of July 20, 2021.

 

(b) Sole power to vote or direct the vote: 0

Shared power to vote or direct the vote: 573,889

Sole power to dispose or to direct the disposition: 0

Shared power to dispose or direct the disposition: 573,889

 

The power to vote or to direct the vote or to dispose or direct the disposition of the Shares reported herein is shared among the Reporting Persons.

 

(c) The following transactions have been effected by 325 over the last 60 days:

 

Purchases

 

Trade Date   Price     Quantity  
05/21/2021   $ 13.8576       16,264  
05/25/2021   $ 13.9900       2,850  
05/26/2021   $ 13.8246       16,270  
05/27/2021   $ 13.9751       10,000  
06/09/2021   $ 13.3800       45,694  
06/22/2021   $ 12.2453       20,806  
06/23/2021   $ 12.3392       11,326  
06/24/2021   $ 12.7994       1,800  
06/25/2021   $ 12.9991       10,179  
06/28/2021   $ 13.1702       4,759  
06/29/2021   $ 13.2300       518  
07/02/2021   $ 13.5293       2,666  
07/06/2021   $ 13.5000       4,106  
07/07/2021   $ 13.2308       7,483  
07/08/2021   $ 13.2985       25,000  
07/08/2021   $ 13.3006       13,424  
07/08/2021   $ 13.2898       11,576  
07/09/2021   $ 13.2843       3,000  
07/12/2021   $ 13.3095       2,800  
07/13/2021   $ 13.2279       25,000  
07/14/2021   $ 13.2066       25,000  
07/15/2021   $ 13.1523       19,509  
07/16/2021   $ 13.1542       13,508  
07/19/2021   $ 12.8904       11,423  

 

   
 

 

Page 8 of 9

 

(d) The Clients have the rights to receive dividends from, and the proceeds from the sale of, the Shares. No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares.

 

(e) Not applicable or complete this section.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

Not applicable.

 

Item 7. Material to be Filed as Exhibits.

 

Exhibit 1 Joint Filing Agreement of the Reporting Persons

 

   
 

 

Page 9 of 9

 

Signatures

 

After reasonable inquiry and to the best of the knowledge and belief of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

 

Dated:  July 20, 2021 325 CAPITAL LLC
     
     
  By: /s/ Michael Braner
  Name  Michael Braner
  Title  Managing Partner
     
  MICHAEL BRANER
     
     
  By: /s/ Michael Braner
  Name  Michael Braner
     
     
  DANIEL FRIEDBERG
     
     
  By: /s/ Daniel Friedberg
  Name  Daniel Friedberg
     
     
  ANIL SHRIVASTAVA
     
     
  By: /s/ Anil Shrivastava
  Name  Anil Shrivastava

 

   
 

 

EXHIBIT 1

 

Joint Filing Agreement

 

The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

 

 

Dated:  July 20, 2021 325 CAPITAL LLC
     
     
  By: /s/ Michael Braner
  Name  Michael Braner
  Title  Managing Partner
     
  MICHAEL BRANER
     
     
  By: /s/ Michael Braner
  Name  Michael Braner
     
     
  DANIEL FRIEDBERG
     
     
  By: /s/ Daniel Friedberg
  Name  Daniel Friedberg
     
     
  ANIL SHRIVASTAVA
     
     
  By: /s/ Anil Shrivastava
  Name  Anil Shrivastava

 

 

 

 

 

 

TransAct Technologies (NASDAQ:TACT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more TransAct Technologies Charts.
TransAct Technologies (NASDAQ:TACT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more TransAct Technologies Charts.